Dechra Pharmaceuticals (LSE:DPH) Days Sales Outstanding : 64.17 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Days Sales Outstanding?

Dechra Pharmaceuticals's average Accounts Receivable for the six months ended in Jun. 2023 was £135.1 Mil. Dechra Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was £384.1 Mil. Hence, Dechra Pharmaceuticals's Days Sales Outstanding for the six months ended in Jun. 2023 was 64.17.

The historical rank and industry rank for Dechra Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

LSE:DPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.25 Med: 60.41 Max: 64.09
Current: 62.66

During the past 13 years, Dechra Pharmaceuticals's highest Days Sales Outstanding was 64.09. The lowest was 50.25. And the median was 60.41.

LSE:DPH's Days Sales Outstanding is not ranked
in the Drug Manufacturers industry.
Industry Median: 71.7 vs LSE:DPH: 62.66

Dechra Pharmaceuticals's Days Sales Outstanding increased from Jun. 2022 (54.24) to Jun. 2023 (64.17).

Dechra Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Dechra Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals Days Sales Outstanding Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

63.30

60.41

50.31

56.29

63.82

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															51.87	47.71	54.24	59.96	64.17

Competitive Comparison of Dechra Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Days Sales Outstanding falls into.

Dechra Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dechra Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (122.1	+	144.2)	/	2 )	/	761.5	*	365
=	133.15					/	761.5	*	365
=	63.82

Dechra Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (125.9	+	144.2)	/	2 )	/	384.1	*	365 / 2
=	135.05					/	384.1	*	365 / 2
=	64.17

Dechra Pharmaceuticals (LSE:DPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Dechra Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines